To make matters worse, the molecular landscape of mesothelioma is mostly dominated by inactivated tumor suppressor genes (NF2, BAP1, TP53, CDKN2A/2B, etc.)rather than druggable driver genes (Bueno et al, 2016), rendering targeted therapy impossible. Here, NF2 is linked to mesothelioma.